microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
about
Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity.The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma.MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1.miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC.miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells.miR-222 promotes invasion and migration of ovarian carcinoma by targeting PTEN.
P2860
Q37554494-D89B1EFD-E573-4DDF-86D4-7E736D34E224Q39099794-A758F5A6-079F-4F2A-BF3D-43F93C4A5A59Q42120428-A7656B9E-8A5C-493A-A749-66CE2FD0C275Q49335091-CBC128FD-EAA2-4199-B48F-CD08C27D88DCQ55354291-D2A8F683-B9B8-49A7-BB5F-3E7DC507B859Q55380508-CF070D38-D56E-4525-81B6-1A7712BF6C12Q55430716-093EB790-BDA0-4AEF-B1F7-0F24863EBC28
P2860
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
@en
type
label
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
@en
prefLabel
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
@en
P2860
P1476
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
@en
P2093
Anne Saumet
Charles-Henri Lecellier
P2860
P356
10.1007/978-3-319-22671-2_2
P407
P577
2015-01-01T00:00:00Z